DeBoer MD - Search Results

1

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. DeBoer MD, et al. Endocrinology. 2007 Jun;148(6):3004-12. doi: 10.1210/en.2007-0016. Epub 2007 Mar 8. Endocrinology. 2007. PMID: 17347304

2

Cachexia: lessons from melanocortin antagonism.

Deboer MD, Marks DL. Deboer MD, et al. Trends Endocrinol Metab. 2006 Jul;17(5):199-204. doi: 10.1016/j.tem.2006.05.005. Epub 2006 Jun 5. Trends Endocrinol Metab. 2006. PMID: 16750633 Review.

3

Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease.

DeBoer MD, Marks DL. DeBoer MD, et al. Nat Clin Pract Endocrinol Metab. 2006 Aug;2(8):459-66. doi: 10.1038/ncpendmet0221. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932335 Review.

4

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.

Deboer MD, Zhu X, Levasseur PR, Inui A, Hu Z, Han G, Mitch WE, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. Deboer MD, et al. Endocrinology. 2008 Feb;149(2):827-35. doi: 10.1210/en.2007-1046. Epub 2007 Nov 26. Endocrinology. 2008. PMID: 18039782 Free PMC article.

5

Administration of IL-1beta to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract.

DeBoer MD, Scarlett JM, Levasseur PR, Grant WF, Marks DL. DeBoer MD, et al. Peptides. 2009 Feb;30(2):210-8. doi: 10.1016/j.peptides.2008.10.019. Epub 2008 Nov 5. Peptides. 2009. PMID: 19028534 Free PMC article.

6

Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.

Barazzoni R, Zhu X, Deboer M, Datta R, Culler MD, Zanetti M, Guarnieri G, Marks DL. Barazzoni R, et al. Among authors: deboer m. Kidney Int. 2010 Jan;77(1):23-8. doi: 10.1038/ki.2009.411. Kidney Int. 2010. PMID: 19890275 Free PMC article.

7

Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?

DeBoer MD. DeBoer MD. Mol Cell Endocrinol. 2011 Jun 20;340(1):97-105. doi: 10.1016/j.mce.2011.02.012. Epub 2011 Feb 25. Mol Cell Endocrinol. 2011. PMID: 21354462 Free PMC article. Review.

8

Emergence of ghrelin as a treatment for cachexia syndromes.

DeBoer MD. DeBoer MD. Nutrition. 2008 Sep;24(9):806-14. doi: 10.1016/j.nut.2008.06.013. Nutrition. 2008. PMID: 18725076 Review.

9

Treatment of cachexia: melanocortin and ghrelin interventions.

Steinman J, DeBoer MD. Steinman J, et al. Among authors: deboer md. Vitam Horm. 2013;92:197-242. doi: 10.1016/B978-0-12-410473-0.00008-8. Vitam Horm. 2013. PMID: 23601426 Review.

10

Update on melanocortin interventions for cachexia: progress toward clinical application.

DeBoer MD. DeBoer MD. Nutrition. 2010 Feb;26(2):146-51. doi: 10.1016/j.nut.2009.07.003. Epub 2009 Dec 8. Nutrition. 2010. PMID: 20004082 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters